renal-cell-carcinoma

Documents about renal-cell-carcinoma

• Detection of Renal Malignancy of Complicated Renal Cysts#877046ClinicalTrials.gov
• A Study of Oncobax®-AK in Patients With Advanced Solid Tumors#162461ClinicalTrials.gov
• Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma#303737ClinicalTrials.gov
• Multiomics Approach in Metastatic Clear Renal Cell Carcnoma#918976ClinicalTrials.gov
• Positron Emission Tomography (PET) Guided Stereotactic Body Radiation Therapy for the Treatment of Oligoprogressive Non-small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma#1033270ClinicalTrials.gov
• 3-AP in Treating Patients With Previously Untreated Locally Recurrent or Metastatic Renal Cell Carcinoma#870303ClinicalTrials.gov
• Inferior vena cava involvement in renal cell carcinoma: if you fail to plan, you’re planning to fail#312134IRIS
• A Pilot Study Evaluating a Ketogenic Diet Concomitant to Nivolumab and Ipilimumab in Patients With Metastatic Renal Cell Carcinoma#369838ClinicalTrials.gov
• Vorolanib Monotherapy or in Combination With Toripalimab as Adjuvant Therapy for Patients With Intermediate-high Risk of Recurrence in Renal Cell Carcinoma#442101ClinicalTrials.gov
• Neoadjuvant Pazopanib in Renal Cell Carcinoma#847894ClinicalTrials.gov
• Combination Sunitinib and Gemcitabine in Sarcomatoid and/or Poor-risk Patients With Metastatic Renal Cell Carcinoma#887788ClinicalTrials.gov
• Cardiovascular and Torsades de Pointes Monitoring for Pazopanib#915679ClinicalTrials.gov
• Optimizing Pazopanib Exposure in RCC Patients#1008894ClinicalTrials.gov
• Study of Nivolumab (BMS-936558) vs. Everolimus in Pre-Treated Advanced or Metastatic Clear-cell Renal Cell Carcinoma (CheckMate 025)#802204ClinicalTrials.gov
• Low-Intensity Stem Cell Transplantation With Multiple Lymphocyte Infusions to Treat Advanced Kidney Cancer#871074ClinicalTrials.gov
• Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial#160371ClinicalTrials.gov
• 68Ga-PSMA PET in the Renal Cell Carcinoma#897921ClinicalTrials.gov
• Residual Normal Renal Parenchymal and Tumor Volume in Tumor Surgeries#919061ClinicalTrials.gov
• Sunitinib Malate in Treating Patients With Previously Untreated Metastatic Kidney Cancer#435812ClinicalTrials.gov
• Systemic Therapy Alone or With Stereotactic Body Radiotherapy for Oligometastatic Kidney Cancer (STROKER Study)#426775ClinicalTrials.gov
• A Prospective Registry Study of Stereotactic Ablative Radiotherapy (SABR) for Oligometastatic/Oligometastatic Renal Cell Carcinoma#451479ClinicalTrials.gov
• An Investigational Immuno-Therapy Safety and Efficacy Study of Multiple Administration Regimens for Nivolumab Plus Ipilimumab in Subjects With Renal Cell Carcinoma#807799ClinicalTrials.gov
• A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)#810239ClinicalTrials.gov
• Study of AS1409 in Patients With Either Metastatic Renal Cell Carcinoma or Metastatic Malignant Melanoma#833897ClinicalTrials.gov
• Identification and Description of Patients With High-risk Non Metastatic RCC#845109ClinicalTrials.gov
• A One-arm Exploratory Clinical Research Program Study of Apatinib in Advanced Metastatic Renal Cell Carcinoma Patients.#862248ClinicalTrials.gov
• Vaccine Therapy With Tumor Specific Mutated VHL Peptides in Adult Cancer Patients With Renal Cell Carcinoma#874987ClinicalTrials.gov
• Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma#891037ClinicalTrials.gov
• Assessing the Utility of Ultrasound Compared to Cross-Sectional Imaging in the Follow-up of Patients With Renal Cell Carcinoma#1010685ClinicalTrials.gov
• Evaluation Of The Impact Of A Call Center In Management Of Metastatic And/Or Advanced Renal Cell Carcinoma Patients Treated With Sunitinib (Sutent) In First Line#966668ClinicalTrials.gov
• Sunitinib Malate and Bevacizumab in Treating Patients With Kidney Cancer or Advanced Solid Malignancies#850489ClinicalTrials.gov
• Immunophenotyping in Metastatic Kidney Cancer Patients Receiving Ablative Therapy#152402ClinicalTrials.gov
• Ketogenic Diet for Patients Receiving Treatment for Metastatic Renal Cell Carcinoma#121326ClinicalTrials.gov
• Study Of Cabozantinib Treatment In Patients With Unresectable, Locally Advanced Or Metastatic Renal Cell Carcinoma Who Progressed After Previous Treatment With Checkpoint Inhibitors#373592ClinicalTrials.gov
• Phase 1b/2 Trial of Ipilimumab, Nivolumab, and Ciforadenant (Adenosine A2a Receptor Antagonist) in First-line Advanced Renal Cell Carcinoma.#918325ClinicalTrials.gov
• A Study of APX005M in Combination With Nivolumab and Ipilimumab in Treatment Naïve Patients With Advanced Melanoma or Renal Cell Carcinoma (RCC)#1009075ClinicalTrials.gov
• Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Carcinoma#846037ClinicalTrials.gov
• Fluorouracil and Low-Dose Suramin as Chemosensitization in Treating Patients With Metastatic Renal Cell (Kidney) Cancer#910302ClinicalTrials.gov
• Sirolimus in Kidney Transplant Patients With Squamous Cell Skin Carcinoma#882670ClinicalTrials.gov
• A Clinical Study of 6MW3211 in Patients With Renal Cancer#1008960ClinicalTrials.gov
• CD70-targeted immunoPET Imaging of Malignant Cancers#847411ClinicalTrials.gov
• Preoperative Therapy of Super-selective Tumor Artery Embolization Combined With Toripalimab and Axitinib in Advanced RCC#897924ClinicalTrials.gov
• Daratumumab in Treating Patients with Muscle Invasive Bladder Cancer or Metastatic Kidney Cancer#884805ClinicalTrials.gov
• A Study to Investigate the Safety and Tolerability of Intravenous QEQ278 in Patients With Advanced Solid Tumors#332738ClinicalTrials.gov
• A Prospective Study of Acute Cardiovascular Effects of First-line Sunitinib in Metastatic Renal Cell Carcinoma Patients (SUnitinib Prospective CardiovasculaR Effect)#160211ClinicalTrials.gov
• The role of pathology in immunotherapy and targeted therapy for renal cell carcinoma#268874IRIS
• Feasibility of a Smart-Phone App for Patients With Advanced Renal Cell Carcinoma Undergoing Combination Immunotherapy#811158ClinicalTrials.gov
• Pembrolizumab and Lenvatinib in Patients With Brain Metastases From Melanoma or Renal Cell Carcinoma#901633ClinicalTrials.gov
• Bilateral renal cell carcinoma with leiomyomatous stroma: a rare entity diagnosed synchronously and treated surgically in a staged fashion#954944Koc University Digital Collections
• Zanzalintinib and MO-03 for the Treatment of Metastatic Renal Cell Cancer After Progression on Immunotherapy#908552ClinicalTrials.gov